15.000
+2,74%
2026-10-19
Fundamental Analysis
93 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +113.6% | +159.6% | 3 / 3 | +95.6% | +5.30 pp | +1.66 pp | +19.2% | 0.53 | 4.77 | 315 | +95,6% | 62,0 | +113,7% | 4.77 | 9.61 | −50,3% |
| Pts | 12 | 12 | 12 | 12 | 12 | 8 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 15.000 (close price on 2026-10-19)EPS (TTM): 3.142
Financial charts
1.Revenue & growth
VND bn315Q2/26
1.Revenue & growth
VND bn315Q2/26
2.Profit & growth
VND bn61,9Q2/26
3.Profit mix (Penman)
VND bn235Q2/26
4.Margins & cost structure
%28.6%Q2/26
5.Returns & cash cycle
% · days21.5%Q2/26
6.Earnings quality & cash
VND bn200Q2/26
7.Asset structure
VND bn1.861Q2/26
8.Funding & debt health
VND bn · times1.861Q2/26
9.Revenue backlog
VND bn28,9Q2/26
10.Valuation
times · %4,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.034Q2/26
Adjusted EPS growth, latest quarter
114%
Average adjusted EPS growth, 3 quarters
160%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26